COVID-19 Therapeutic Treatment is World’s First Synthetic Biological Drug to Receive FDA Approval for Phase III TrialsPR-M11-20-034
Gattefossé Continues Its International Development and Builds a Production Site in TexasPR-M11-20-033
TrakCel Celebrates 10 years of Market Leading Cell Orchestration Solutions by Setting out Future PlansPR-M08-22-04
RoosterBio and AGC Biologics Announce Collaboration to Accelerate Manufacturing of Cell and Exosome TherapiesPR-M08-22-03
Be The Match BioTherapies® Now Offers A Central Point of Access To Fully-Characterized Cord Blood Units for Commercial and Clinical UsePR-M08-22-02
Sartorius to Acquire Albumedix, Creating a Powerhouse for Innovative Advanced Therapy SolutionsPR-M08-22-01
ENR Ranks CRB Among Top Design and Construction Firms for Life Sciences, Food and Beverage facilitiesPR-M07-22-07
Procurement Leader Valerie Silva Joins CRB as Company Addresses Supply Chain, Risk ChallengesPR-M07-22-06
Dotmatics Launches Small Molecule Drug Discovery Solution Helping Researchers Accelerate Life-Improving TherapiesPR-M07-22-05
Piramal Pharma Solutions Holds Grand Opening Ceremony for New API Plant at Aurora, Canada Manufacturing SitePR-M07-22-04